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Rickettsia 
aeschlimannii: 
A New Pathogenic 
Spotted Fever 
Group Rickettsia, 
South Africa
To the Editor: Spotted fever
group rickettsiae are increasingly rec-
ognized as agents of disease in resi-
dents of and tourists to South Africa
(1). To date, two species, Rickettsia
conorii and R. africae, which cause
Mediterranean spotted fever (MSF)
and African tick-bite fever (ATBF),
respectively, have been associated
with human disease in the region;
ATBF is more frequently associated
with travel (1). As different antibiotic
regimens are recommended for the
two syndromes, differentiating MSF
from ATBF is important. Increasing
evidence shows that the syndromes
can usually be differentiated through
clinical manifestations and epidemio-
logic characteristics (1).
We recently encountered a South
African patient who, on returning
from a hunting and fishing trip, dis-
covered a Rhipicephalus appendicula-
tus tick attached to his right thigh and
an eschar around the attachment site.
The patient was aware of the risk of
tick-transmitted disease; after remov-
ing the tick, immediately self-pre-
scribed doxycycline. No further
symptoms developed. However, as a
precaution, the patient went to a local
clinic, where a skin biopsy was taken
from the eschar. This sample, together
with the removed tick, was submitted
to our laboratory. DNA extracts, pre-
pared from an eschar biopsy and the
tick, were incorporated into a poly-
merase chain reaction (PCR) assay
specifically targeting a fragment of the
rickettsial ompA (2). Sequence analy-
sis of the amplification products
showed both to be identical and to
share >99% similarity with the ompA
of R. aeschlimannii, a species not pre-
viously associated with human dis-
ease. Unfortunately, blood samples
could not be collected at the time the
patients first had symptoms; thus,
investigation of a disseminated infec-
tion by PCR and serologic testing was
not possible.
Although genotypically indistin-
guishable organisms had previously
been detected in Hyalomma mar-
ginatum collected in Portugal and
Zimbabwe, R. aeschlimannii was first
characterized following its isolation
from H. marginatum ticks in Morocco
(3) and recently in Niger  (4). This
encounter was the first demonstration
of its presence in South Africa and in
Rhipicephalus ticks.
A lack of suitable clinical material
prevented full evaluation of the patho-
genic potential of R. aeschlimannii in
this patient and prompt antibiotic
intervention may have prevented evo-
lution of the syndrome. Nonetheless,
that R. aeschlimannii was transmitted
to the patient and established a local
infection leading to eschar formation
provides clear, albeit preliminary, evi-
dence of its virulence. Until further
cases are encountered, allowing better
characterization of the clinical mani-
festations associated with R. aeschli-
mannii infection and considering the
agent capable of inducing either MSF
or ATBF-like manifestations is cru-
cial; neither of these syndromes can be
associated with a specific causative
agent without microbiologic identifi-
cation. Our findings demonstrate that
Rickettsia species first encountered in
tick surveys are associated with
human disease, and we should not
assume that some Rickettsia species
not have a pathogenic potential.
Anne-Marié Pretorius* 
and Richard J. Birtles†
*University of the Free State, Bloemfontein,
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Age as a Risk 
Factor for 
Cutaneous Human 
Anthrax: Evidence 
from Haiti, 
1973–1974
To the Editor: Few cases of
anthrax have been reported in chil-
dren, in part because most exposures
to Bacillus anthracis occur in work-
place settings. Questions about the
susceptibility of children to B. anthra-
cis infection were raised when cutane-
ous anthrax developed in a 7-month-Emerging Infectious Diseases  •  Vol. 8, No. 8, August 2002 875
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old child in New York City in 2001
after he was taken to visit his mother’s
workplace (1). No cases of anthrax
were reported in persons <24 years of
age in the 1979 inhalational anthrax
outbreak in the Soviet city of Sverd-
lovsk, despite a presumed general
population exposure (2). Such reports
have led some investigators to postu-
late that young persons may be less
susceptible to anthrax than older
persons.
In 1974, the Center for Disease
Control reviewed records on the
occurrence of human anthrax in Dis-
trict Sanitaire des Cayes, Haiti, as part
of an investigation of cutaneous
anthrax in a Florida woman exposed
to spore-contaminated goatskin drums
she purchased in Haiti (3). In 1973, a
total of 387 cases (7.6 per 10,000 pop-
ulation) were clinically diagnosed in
District Sanitaire des Cayes; another
59 cases occurred in the first 4 months
of 1974. All cases were the cutaneous
form; gastrointestinal and inhalational
anthrax are rarely, if ever, diagnosed
in Haiti. The source of infection in
these 446 patients could not be deter-
mined. Although cases of animal
anthrax were rarely reported in Haiti
because of a weak surveillance sys-
tem, 96 (26%) of 368 Haitian goatskin
handicraft items were found to be con-
taminated with B. anthracis during the
1974 investigation, suggesting that
animal infections were not uncommon
(4). Therefore, the source of the infec-
tion may have been meat and other
products of value salvaged by local
residents from anthrax-infected ani-
mals. 
Age was reported for 366 of the
446 patients in District Sanitaire des
Cayes (Table). The distribution of
anthrax cases by age group was gener-
ally similar to that of the general pop-
ulation, except the proportion of cases
in the 15- to 44-year age group was
lower than the proportion of persons
in that age group in the general popu-
lation (p<0.03; chi square). In 124
patients for whom information was
available, the cutaneous lesion was
located on the head or neck (60
patients [48%]), the arm (31 [25%]),
the trunk (23 [19%]), and the leg (12
[10%]); this anatomic distribution,
reflecting the primary skin contact
point of the organism, was similar in
all age groups. However, determining
whether the various age groups had
differences in skin contact exposure
leading to infection is difficult. The
affected rural population lived in
extreme poverty, typically in small
huts with dirt floors and no safe water
supply or latrine. Malnutrition was
epidemic, and nothing edible was dis-
carded. The crowded living conditions
limited opportunities to maintain basic
personal hygiene and made it likely
that exposure to B. anthracis–contam-
inated materials was similar across all
age groups. These previously unpub-
lished age-specific anthrax attack rates
from Haiti suggest that adults and
children have similar susceptibility to
cutaneous anthrax.
Arnold F. Kaufmann 
and Andrew L. Dannenberg
Centers for Disease Control and Prevention
Atlanta, Georgia, USA
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Table. Reported ages of persons with cutaneous anthrax, District Sanitaire des Cayes, Haiti, 
1973–74 
Age group (yrs)
Anthrax patients
No. (%) 
General population
No. (%) Cases per 10,000 persons
  <1   15 (4.1)  16,361 (3.2) 9.2
 1–4   49 (13.4)  59,291 (11.6) 8.3
 5–14  96 (26.2) 120,532 (23.5) 8.0
15–44  135 (36.9) 235,164 (45.8) 5.7
45–64  58 (15.8)  64,882 (12.7) 8.9
  >65  13 (3.6)  16,669 (3.2) 7.8
All ages 366 512,899 7.1
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